SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
Directive transparence : information réglementée
18/03/2023 15:00
18/03/2023 15:00
18/03/2023 15:00
16/03/2023 21:06
16/03/2023 21:06
14/03/2023 19:27
14/03/2023 19:27
02/03/2023 08:00
02/03/2023 08:00
24/02/2023 17:16
23/02/2023 22:00